Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Encapsulating peritoneal sclerosis (EPS) is a major cause that prevent long-term peritoneal dialysis leading to a loss of quality of life in patients. In this study, we developed bionanoparticle which prevented peritoneal inflammation by its internal antioxidant and enhanced absorption of low molecular-weight uremic toxins by its contained silica. The developed nanoparticle: silica-contained redox nanoparticle (SiRNP), effectively suppressed the peritoneal thickness in EPS model when it was contained to peritoneal dialysate. In addition, SiRNP decreased blood urea nitrogen and serum creatinine levels in renal failure model.
|